Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

An umbrella review finds distinct iron-related MRI changes in ALS

Original source

Quantitative susceptibility mapping in neurodegenerative diseases: An umbrella review of iron-related biomarkers and mechanisms.Magn Reson Imaging · 3 August 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Study type
Review
Studied in
Human

Population inferred from the title and abstract by Compass.

Article

View article on the publisher's site (opens in a new tab)via the publisher — full text availability varies

An umbrella review found that quantitative susceptibility mapping, an advanced magnetic resonance imaging technique, detects disease-specific changes in tissue magnetic susceptibility in ALS and other neurodegenerative diseases. In ALS, reported changes involved the thalamus, motor cortex and hippocampus, and were associated with cognitive impairment and upper motor neuron signs. The review described QSM as promising for diagnosis and for studying iron-related mechanisms, but did not establish a treatment benefit.

Why this matters

These findings may help researchers investigate iron-related changes in ALS and assess whether QSM could support future diagnosis or disease monitoring. They do not currently change treatment for people living with ALS because the review evaluated existing evidence rather than demonstrating a clinical benefit or treatment effect.

Limitations and context

This was an umbrella review of 15 systematic reviews and meta-analyses, not a new clinical study. Thirteen of the 15 reviews were rated low or critically low quality, and the evidence was heterogeneous. The review authors also reported only slight overlap among the underlying primary studies, so the ALS findings should be interpreted cautiously. The source does not establish whether QSM improves diagnosis or monitoring in routine clinical care.

Summarised by Compass 8 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?